NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 2—design, manufacturing, and testing of the ultraviolet and visible channel

NOMAD is a spectrometer suite on board the ESA/Roscosmos ExoMars Trace Gas Orbiter, which launched in March 2016. NOMAD consists of two infrared channels and one ultraviolet and visible channel, allowing the instrument to perform observations quasi-constantly, by taking nadir measurements at the day- and night-side, and during solar occultations. Here, in part 2 of a linked study, we describe the design, manufacturing, and testing of the ultraviolet and visible spectrometer channel called UVIS. We focus upon the optical design and working principle where two telescopes are coupled to a single grating spectrometer using a selector mechanism

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

Background and purpose: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). Results: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. Conclusions: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality.

BACKGROUND AND PURPOSE: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. METHODS: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). RESULTS: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. CONCLUSIONS: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT

Growth, Productivity, Biomass and Carbon Stock in Eucalyptus saligna and Grevillea robusta Plantations in North Kivu, Democratic Republic of the Congo

Initiated by the World Wildlife Fund (WWF) more than a decade ago in North Kivu, single-species plantations of Eucalyptus saligna and Grevillea robusta constitute, with other village plantations, the current legal source of wood-energy for the communities bordering the Virunga National Park (PNVi). This study assesses the growth and productivity of these plantations in two sites with different soil and climatic conditions to predict their production over time. The study also assesses the carbon stock and long-term CO2 fixation in the biomass of the studied plantations to deduce their contribution to climate change mitigation. Non-destructive inventories were carried out during three consecutive years in 20 E. saligna and 12 G. robusta plantations in Sake and Kirumba. Analysis of the data revealed that both species have similar diametric growth while height growth and productivity were significantly higher in the E. saligna plantations. The productivity of E. saligna was also higher in Kirumba than in Sake, while that of G. robusta was higher in Sake than in Kirumba. The differences observed were mainly related to species, silviculture, altitude and concentration of bioavailable elements in the soils. The analysis of productivity evolution over time allowed us to determine optimal rotations at 8 and 12 years, respectively, for E. saligna and G. robusta plantations. The relationships between biomass or carbon stock and tree diameter were not different between the studied species but were significantly different at the stand level. If silviculture was standardized and plantations carefully monitored, carbon stock and long-term CO2 fixation would be higher in G. robusta plantations than in E. saligna plantations. These results indicate that while for productivity reasons E. saligna is the favoured species in wood-energy plantations to quickly meet the demand of the growing and disadvantaged population living in the vicinity of PNVi, carefully monitored G. robusta plantations could be more interesting in terms of carbon credits. To simultaneously optimise wood-energy production and carbon storage in the plantations initiated in North Kivu, E. saligna and G. robusta should be planted in mixture. In addition, species and site characteristics adapted silvicultural management practices must be applied to these plantations, which are very important for the region, its population and its park. Finally, the economic profitability as well as the sustainability of the plantations should be assessed in the longer term in North Kivu

Influence of spacing and seed trees on the growth of Pericopsis elata saplings during the first twenty months of a planting trial

Description of the subject. Pericopsis elata (Fabaceae) is a long-lived light-demanding tree from African rain forests that produces timber of high economic value. Natural populations suffer from overexploitation and a deficit of natural regeneration. Plantations could increase its production and limit the pressure on natural forests. However, we lack knowledge on the influence of spacing and seed tree origin on tree growth to optimize plantation protocols. Objectives. This study evaluated the impact of sapling density and seed tree origin on the growth in diameter and height of P. elata plants, 20 months after plantation. Method. Seeds were collected on 19 mother trees in a 400 ha natural stand near Kisangani (DRC). In October 2017, seedlings were transplanted in a Nelder design plantation with three replicates, to compare sapling growth at 10 contrasting plant densities under full sun. Diameter and height increments of 540 plants were analyzed according to local competition and maternal origin using generalized additive models. Results. Twenty months after planting, height growth peaked at an intermediate density of 47,000 stems·ha-1 (165.6 ± 39.2 cm·year-1), while diameter growth peaked at a lower density of 4,200 stems·ha-1 (24.6 ± 8.3 mm·year-1). The maternal origin of saplings affected their growth, the coefficients of variation among mother trees reaching 7.6% and 6.4% for diameter and height increments, respectively. The initial diameter affected positively diameter growth while the initial height did not influence height growth. Conclusions. The Nelder design proved useful to assess how plant growth depends both on spacing and genetic factors

Experimental and Theoretical Study of the Plasma Chemistry of Ethyl Lactate Plasma Polymerization Discharges

International audienc

AutoMoDe-Arlequin: Neural Networks as Behavioral Modules for the Automatic Design of Probabilistic Finite-State Machines

We present Arlequin, an off-line automatic design method that produces control software for robot swarms by combining behavioral neural-network modules generated via neuro-evolution. The neural-network modules are automatically generated once, in a mission-agnostic way, and are then automatically assembled into probabilistic finite-state machines to perform various missions. With Arlequin, our goal is to reduce the amount of human intervention that is required for the implementation or the operation of previously published modular design methods. Simultaneously, we assess whether neuro-evolution can be used in a modular design method to produce control software that crosses the reality gap satisfactorily. We present robot experiments in which we compare Arlequin with Chocolate, a state of the art modular design method, and EvoStick, a traditional neuro-evolutionary swarm robotics method. The preliminary results suggest that automatically combining neural-network modules into probabilistic finite-state machines is a promising approach to the automatic conception of control software for robot swarms.SCOPUS: cp.kinfo:eu-repo/semantics/publishe

Residual cerebral functioning in the vegetative state

peer reviewe

The impact of COVID-19 on acute stroke care in Belgium

A worldwide decline in stroke hospitalizations during the COVID-19 pandemic has been reported. Information on stroke care during the pandemic in Belgium is lacking. This study aims to analyze the impact of COVID-19 on acute stroke care in eight Belgian stroke centers. This Belgian study is part of an international observational and retrospective study in 70 countries and 457 stroke centers. We compared volumes of COVID-19 and stroke hospitalizations, intravenous thrombolysis and endovascular treatment rates, acute treatment time intervals and functional outcome at 90 days during the first wave of the pandemic to two control intervals (March–May 2019 and December–February 2020). From March 2020 to May 2020, 860 stroke patients were hospitalized. In the same time period, 2850 COVID-19 patients were admitted, of which 37 (1.3%) were diagnosed with a stroke. Compared to the months prior to the pandemic and the same time epoch one year earlier, stroke hospitalizations were reduced (relative difference 15.9% [p = 0.03] and 14.5% [p = 0.05], respectively). Despite a reduction in absolute volumes, there was no difference in the monthly proportion of thrombolysis or endovascular treatment provided to the overall stroke hospitalizations. Acute treatment time metrics did not change between COVID-19 pandemic and control time epochs. We found no difference in 90-day functional outcomes nor in mortality after stroke between patients admitted during the pandemic versus control periods. We found a decline in the volume of stroke hospitalizations during the first wave of the COVID-19 pandemic in Belgium. Stroke care quality parameters remained unchanged